Larry A. Greenbaum

Terminal Complement Inhibitor Eculizumab in Atypical Hemolytic–Uremic Syndrome

Christophe Legendre, Christoph Licht, Petra Muus et al. · New England Journal of Medicine · 2013 · 1.6K citations · Full text

Medicine, Hematology, Pharmacotherapy +17

Efficacy and safety of eculizumab in atypical hemolytic uremic syndrome from 2-year extensions of phase 2 studies

Christoph Licht, Larry A. Greenbaum, Petra Muus et al. · Kidney International · 2015 · 415 citations · Full text

Pharmacy, Hematology, Pharmacotherapy +17

Design of the Nephrotic Syndrome Study Network (NEPTUNE) to evaluate primary glomerular nephropathy by a multidisciplinary approach

Crystal A. Gadegbeku, Debbie S. Gipson, Lawrence B. Holzman et al. · Kidney International · 2013 · 350 citations

Medicine, Internal Medicine, Nephrology +14

Management of Childhood Onset Nephrotic Syndrome

Debbie S. Gipson, Susan F. Massengill, Lynne Yao et al. · PEDIATRICS · 2009 · 312 citations

Medicine, Nephrology, Pediatrics +17

Eculizumab is a safe and effective treatment in pediatric patients with atypical hemolytic uremic syndrome

Larry A. Greenbaum, Marc Fila, Gianluigi Ardissino et al. · Kidney International · 2016 · 294 citations · Full text

Medicine, Pediatrics, Pharmacotherapy +14